Surgery
Volume 146, Issue 6 , Pages 1021-1027 , December 2009

Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: A 10-year outcome

  • John I. Lew, MD

      Affiliations

    • Corresponding Author InformationReprint requests: John I. Lew, MD, Assistant Professor of Surgery, DeWitt Daughtry Family Department of Surgery, Division of Endocrine Surgery, University of Miami Leonard M. Miller School of Medicine, 1475 NW 12th Avenue, Room 3524, Miami, FL 33136.
    • ,
  • George L. Irvin III, MD

,Accepted 17 September 2009.

References 

  1. Sackett WR, Barraclough B, Reeve TS, et al. World trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg. 2002;137:1055–1059
  2. Udelsman R. Six hundred fifty six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665–672
  3. Westerdahl J, Lindblom P, Bergenfelz A. Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg. 2002;137:186–190
  4. Irvin GL, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239:704–708
  5. Grant CS, Thompson G, Farley D, et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472–478
  6. Chen H, Pruhs Z, Starling JR, et al. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–590
  7. Molinari AS, Irvin GL, Deriso GT, et al. Incidence of multiglandular disease in primary hyperparathyroidism determined by parathyroid hormone secretion. Surgery. 1996;120:934–937
  8. Purcell GP, Dirbas FM, Jeffrey RB, et al. Parathyroid localization with high-resolution ultrasound and technetium Tc 99 m sestamibi. Arch Surg. 1999;134:824–830
  9. Carneiro DM, Solorzano CC, Nader MC, et al. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?. Surgery. 2003;134:973–981
  10. Siperstein A, Berber E, Mackey R, et al. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery. 2004;136:872–880
  11. Clerici T, Brandle M, Lange J, et al. Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg. 2004;28:187–192
  12. Haciyanli M, Lal G, Morita E, et al. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg. 2003;197:739–746
  13. Siperstein A, Berber E, Barbosa GF, et al. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg. 2008;248:420–428
  14. Lee NC, Norton JA. Multiple gland disease in primary hyperparathyroidism: a function of operative approach?. Arch Surg. 2002;137:896–900
  15. Sidhu S, Neill AK, Russell CFJ. Long-term outcome of unilateral parathyroid exploration for primary hyperparathyroidism due to presumed solitary adenoma. World J Surg. 2003;27:339–342
  16. Westerdahl J, Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg. 2007;246:976–981
  17. Russell CFJ, Dolan SJ, Laird JD. Randomized clinical trial comparing scan directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br J Surg. 2006;93:418–421
  18. Mun HC, Conigrave A, Wilkinson M, et al. Surgery for hyperparathyroidism: does morphology or function matter most?. Surgery. 2005;138:1111–1120
  19. Elliott DD, Monroe DP, Perrier ND. Parathyroid histopathology: is it of any value today?. J Am Coll Surg. 2006;203:758–765
  20. Carneiro-Pla DM, Romaguera R, Nadji M, et al. Does histopathology predict parathyroid hypersecretion and influence correctly the extent of parathyroidectomy in patients with sporadic primary hyperparathyroidism?. Surgery. 2007;142:930–935
  21. Consensus Development Conference Panel . Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference statement. Ann Intern Med. 1991;114:593–597
  22. Irvin GL, Carneiro DM. Management changes in primary hyperparathyroidism. JAMA. 2000;284:934–936
  23. Irvin GL, Prudhomme DL, Deriso GT, et al. A new approach to parathyroidectomy. Ann Surg. 1994;219:574–581
  24. Irvin GL, Sfakianakis G, Yeung L, et al. Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch Surg. 1996;131:1074–1078
  25. Irvin GL, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg. 2004;28:1287–1292

 Presented at the 30th Annual Meeting of the American Association of Endocrine Surgeons, Madison, Wisconsin, May 3–5, 2009.

PII: S0039-6060(09)00535-2

doi: 10.1016/j.surg.2009.09.006

Surgery
Volume 146, Issue 6 , Pages 1021-1027 , December 2009

Article Tools

* Image Usage & Resolution